Neuralink, the neurotech startup co-founded by Elon Musk, has received approval from the Food and Drug Administration to conduct its first in-human clinical study of its brain implant device. The device, called the Link, is designed to help patients with severe paralysis control external technologies using only neural signals. This means patients with severe degenerative…